Sodium Imbalances: Hyponatremia and Hypernatremia - Comprehensive Notes

Hyponatremia (Sodium Deficit)

  • Definition and normal range:
    • Hyponatremia is a serum sodium level 2e2; 135 mEq/L ( i.e.,
      ext{serum Na} < 135\ \mathrm{mEq/L} )
    • Normal value is 135−145 mEq/L135-145\ \mathrm{mEq/L}
  • Forms and clinical context:
    • Acute hyponatremia: due to rapid sodium decline often from fluid overload in a surgical patient
    • Chronic hyponatremia: more common outside the hospital setting
    • Exercise-associated hyponatremia is frequently seen in women or individuals with smaller body builds
  • Pathophysiology (core concepts):
    • Primarily due to an imbalance of water vs. sodium (water excess relative to sodium)
    • Urine sodium helps differentiate renal from nonrenal causes
    • Low urine sodium (e.g., extUrineNa≤20  mmol/Lext{Urine Na} \leq 20\ \,\mathrm{mmol/L}) suggests renal sodium retention to compensate for nonrenal fluid loss (vomiting, diarrhea, sweating)
    • High urine sodium is associated with renal salt wasting and diuretic use
    • Aldosterone deficiency (e.g., adrenal insufficiency) predisposes to sodium loss
    • Anticonvulsants can predispose to hyponatremia
    • SIADH (syndrome of inappropriate antidiuretic hormone secretion) is a key physiologic disturbance
    • Excessive ADH activity leads to water retention and dilutional hyponatremia with inappropriate urinary excretion of sodium
  • Diagnostic approach (pathway highlights):
    • Assess dehydration status
    • Is urinary Na > 20 mmol/L20\ \mathrm{mmol/L}? → indicates renal Na loss (e.g., Addison's disease, renal failure, diuretic excess, osmolar diuresis)
    • Is there loss elsewhere (diarrhea, vomiting, fistulae, burns, SBO, trauma, CF, heat exposure)?
    • Is urine osmolality > 500 mOsm/kg500\ \mathrm{mOsm/kg}? → suggests nephrotic syndrome, cardiac failure, cirrhosis, renal failure with water retention
    • Consider inappropriate ADH activity with water overload; assess for severe hypothyroidism or glucocorticoid insufficiency
    • Note a schematic of causes often shown as: Decreased Na intake/Restricted intake; Increased Na excretion (diuretics, diaphoretic losses); Dilutional from excess free water; Nonrenal vs renal losses; ADH disturbances
  • Causes of hyponatremia (major categories):
    • Increased sodium excretion/diuretic-related losses
    • Excessive diaphoresis, diuretics, vomiting, diarrhea, wound drainage (GI)
    • Renal disease, decreased aldosterone secretion
    • Inadequate sodium intake
    • NPO, low-salt diet
    • Dilutional hyponatremia
    • Ingestion of hypotonic fluids or irrigation with hypotonic fluids
    • Other contributors
    • Renal failure, freshwater drowning, SIADH, hyperglycemia, congestive heart failure
  • Clinical manifestations (systemic impact depends on cause, magnitude, and speed of onset):
    • Systemic approach: Cardiovascular, Respiratory, Neuromuscular, Cerebral function, Gastrointestinal, Renal
  • Cardiovascular (S/SX):
    • Vascular volume dependent:
    • Normovolemic: rapid pulse, normal BP
    • Hypovolemic: thready/rapid pulse, hypotension, flat neck veins, normal/low JVP
    • Hypervolemic: rapid, bounding pulse; BP normal/elevated; JVP normal/elevated
  • Respiratory & Neuromuscular:
    • Respiratory: shallow, ineffective movements (late, related to skeletal muscle weakness)
    • Neuromuscular: generalized skeletal muscle weakness (worse in extremities); diminished deep tendon reflexes; pitting edema
  • Cerebral function (neurocognitive impact):
    • Headache, personality changes, confusion, seizures, coma
  • Gastrointestinal & Renal:
    • GI: increased motility, hyperactive bowel sounds, nausea, abdominal cramping, diarrhea
    • Renal: decreased urinary specific gravity, increased urinary output
  • Diagnostic findings:
    • Physical exam and history; medication review
    • Serum osmolality
    • Urinary sodium content
    • Urine specific gravity
  • Medical management (principles):
    • Focus on clinical symptoms and underlying condition
    • Core strategies:
    • Sodium replacement when needed
    • Water restriction when appropriate
    • Pharmacologic therapy for specific etiologies
  • Sodium replacement (treatment of choice):
    • Routes: oral, nasogastric tube (NGT), or parenteral
    • Fluids commonly used: Lactated Ringer's solution or normal saline (NSS)
    • Safety threshold: Serum sodium must not increase by more than 12 mEq/L12\ \mathrm{mEq/L} in 24 h24\ \mathrm{h} to avoid neurologic injury from demyelination
    • Risks of overcorrection: rapid correction can mimic myelin destruction; may present with altered cognition, decreased alertness, ataxia, paraparesis, dysarthria, horizontal gaze paralysis, pseudobulbar palsy, and coma
  • Water restriction (fluid management):
    • For patients with normal/excess fluid, hyponatremia is managed with fluid restriction
    • Severe hyponatremia with neurological deficits may require small volumes of hypertonic saline to treat cerebral edema
    • Dangers of hypertonic solutions when used inappropriately
    • Practical hypertonic dosing example:
    • 1 L1\ \mathrm{L} of 3% NaCl3\%\ NaCl contains 513 mEq/L513\ \mathrm{mEq/L}
    • 1 L1\ \mathrm{L} of 5% NaCl5\%\ NaCl contains 855 mEq/L855\ \mathrm{mEq/L}
    • Recommendation: administer 3% NaCl3\%\ NaCl at 0.10−1.0 mL/kg/h0.10-1.0\ \mathrm{mL/kg/h}
  • Pharmacologic therapy (ADH pathway modulation):
    • Arginine vasopressin (AVP) receptor antagonists promote free water excretion
    • Conivaptan hydrochloride (Vaprisol): IV, limited to hospitalized patients; for moderate to severe symptomatic hyponatremia; contraindicated with seizures, delirium, or coma
    • Tolvaptan (Samsca): oral; indicated for clinically significant hypervolemic and euvolemic hyponatremia
  • Nursing interventions:
    • Monitor cardiovascular, respiratory, neuromuscular, cerebral, renal, and gastrointestinal status
    • If hyponatremia coexists with hypovolemia, administer IV saline to restore sodium and volume
    • If hyponatremia coexists with hypervolemia, use osmotic diuretics to promote water loss (not sodium loss)
    • If there is inappropriate/excess ADH secretion, consider ADH antagonists (e.g., lithium or demeclocycline/Declomycin)
  • Lithium considerations (if patient is on lithium):
    • Monitor lithium level because hyponatremia can reduce lithium excretion and cause toxicity
  • Dietary considerations: sodium intake enhancement
    • Common high-sodium foods include: Bacon, Butter, Canned foods, Ketchup, Luncheon meats, Mustard, Processed foods, Snack foods, Soy sauce, Table salt, White and whole-wheat bread, Milk, Cheese

Hypernatremia (Sodium Excess)

  • Definition and normal range:
    • Hypernatremia is a serum sodium level > 145 mEq/L145\ \mathrm{mEq/L}
  • Causes and pathophysiology (core concepts):
    • Occurs with either a gain of sodium in excess of water or a loss of water in excess of sodium
    • Can occur with normal fluid status, or with fluid volume deficit (FVD) or fluid volume excess (FVE)
    • The patient ingests or retains more sodium than water
  • Common etiologies (pathophysiology highlights):
    • Fluid deprivation or lack of access to water (especially in very old, very young, and cognitively impaired patients)
    • Hypertonic enteral feedings without adequate water supplementation
    • Watery diarrhea, insensible water loss (e.g., fever, burns, hyperventilation)
    • Diabetes insipidus (DI)
    • Drowning in seawater (high sodium content ~ 500 mEq/L500\ \mathrm{mEq/L})
    • Malfunction of hemodialysis/peritoneal dialysis systems
    • IV administration of hypertonic saline or excessive use of sodium bicarbonate
    • Exertional dysnatremia (in athletes)
    • Exercise-associated hyponatremia can present with similar CNS symptoms, but this is typically hyponatremia; hypernatremia can arise with extreme water loss during exercise or fever
  • Non-renal vs renal losses (conceptual framework):
    • Non-renal losses: insensible losses (fever, burns), GI losses (diarrhea), respiratory losses (hyperventilation), increased water loss without adequate intake
    • Renal losses: diabetes insipidus (DI), osmotic diuresis, central vs nephrogenic DI with dilute urine
  • Causes of hypernatremia (detailed):
    • Decreased sodium excretion (e.g., Cushing’s syndrome, corticosteroid use, renal failure, hyperaldosteronism)
    • Increased sodium intake (excessive oral intake or IV fluids with sodium)
    • NPO or inadequate water intake
    • Increased water loss: fever, hyperventilation, infection, diaphoresis, watery diarrhea, diabetes insipidus
  • Clinical manifestations (systemic impact due to increased plasma osmolality):
    • Water shifts from intracellular to extracellular space causing cellular dehydration and concentrated extracellular fluid
    • Systemic approach: Cardiovascular, Respiratory, Neuromuscular, Central Nervous System (CNS), Renal, Integumentary
  • Cardiovascular & Respiratory S/SX:
    • Heart rate and blood pressure reflect volume status
    • Hypervolemia can lead to pulmonary edema
  • Neuromuscular S/SX:
    • Early: spontaneous muscle twitches, irregular contractions
    • Late: skeletal muscle weakness; diminished or absent deep tendon reflexes
  • Central Nervous System S/SX:
    • Normovolemia/hypovolemia: agitation, confusion, seizures
    • Hypervolemia: lethargy, stupor, coma
  • Renal & Integumentary S/SX:
    • Renal: increased urinary specific gravity, decreased urinary output
    • Integumentary: dry skin; edema may be present or absent depending on fluid status
  • Diagnostic findings:
    • Serum osmolality
    • Urine specific gravity and urine osmolality
    • Nephrogenic or central DI tends to produce dilute urine with urine osmolality < 250 mOsm/kg250\ \mathrm{mOsm/kg}
  • Medical management (treatment goals and approaches):
    • Gradual reduction of serum sodium using hypotonic electrolyte solutions (e.g., 0.3% NaCl0.3\%\ NaCl) to avoid cerebral edema and to be safer than D5W when sodium needs to be lowered while providing some solute-free water
    • Isotonic non-saline solution (e.g., D5W) when water needs replacement without sodium
    • Diuretics to treat sodium gain when appropriate
    • Target rate of correction: 0.5−1 mEq/L/h0.5-1\ \mathrm{mEq/L/h} to allow gradual diffusion readjustment across compartments
    • Desmopressin acetate (DDAVP) for DI if DI is the cause of hypernatremia
  • Nursing interventions:
    • Monitor patients at risk for hypernatremia; assess cardiovascular, respiratory, neuromuscular, cerebral, renal, and integumentary status
    • If fluid loss is the cause, prepare to administer IV infusions to restore hydration
    • If renal excretion of sodium is impaired, consider diuretics that promote sodium loss
    • Restrict sodium and fluids as prescribed to gradually normalize levels
  • Notes on numerical values and safety considerations:
    • Rapid correction of hypernatremia can precipitate cerebral edema; the correction should be gradual per protocol
    • Monitor for signs of overcorrection or dehydration during therapy
  • Summary of key thresholds and agents:
    • Hypernatremia: ext{Serum Na} > 145\ \mathrm{mEq/L}
    • Goal correction rate: 0.5−1 mEq/L/h0.5-1\ \mathrm{mEq/L/h}
    • Hypotonic saline option: 0.3% NaCl0.3\%\ NaCl
    • Isotonic water replacement option: D5WD5W
    • DDAVP for DI-related hypernatremia